Yes, I watched both the AGM and Dr. Tapson's roadmap presentation. I agree that the team is genuinely excited about Akida 2 and future iterations. The potential of the Akida is huge, and I definitely believe in what it can achieve, thats why I'm heavily invested. However, from a commercial revenue standpoint, the outlook remains unclear over the next 12-18 months.JB49 don't know if you were at the AGM or watched it online, but the roadmap before the AGM presented by Dr Tapson is really worth watching (not sure if it's out yet). I thought his presentation was the best part of the day. He was genuinely excited, and I think if you listed to this, you'll get some good things out of it.
The enthusiasm within the company for the product technology is clear, but translating that into market traction seems to be a much more complex process than initially anticipated. And thats what I could sense from management in the AGM. They are frustrated. They are frustrated because they know they have an amazing product, but one that is taking a lot longer for the market to start adopting it. And thats where I feel the lack of confidence was stemming from. Hence why I'm suggesting that we should start seeing commercial success from 2027-2029. If that makes me a dumb arse then so be it. But I prefer to be realistic.
Chipman - let me know where you think significant revenue is coming from before 2027. Keen to hear your thoughts.